Accreditation Results 2006

Category One: A&B	Category Two:C	Category Three:D
Haykal	Beirut General Hospital	Al Assi
Nini	Beit Chabab	Baaklin
Notre Dame de Secours	Bissar	Saint Georges Hadath
Sahel General	Chtaura
Saint Charles	Clinic du Levant
Saint Therese	Doctor's Hospital Al Manara
Saydet Zgharta	Farhat Jib Janine
St. Joseph	Fouad Khoury
Al Salame- Hopital de la Paix	Geitawi
Dar Al-Amal	Hayek
Saint Georges-Ajaltoun	Hiram
St. Louis	Iklim Health Foundation
	Mais
	Najjar
	Tannourine

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01EA04	BOSULIF	B	Bosutinib - 400mg	400mg	Tablet, film coated	L.L
L01EA04	BOSULIF	B	Bosutinib - 500mg	500mg	Tablet, film coated	L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	49,522,064 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	49,522,064 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	L.L
L01XG01	BORTEZOMIB SPC	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	15,743,401 L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	L.L
L01XG01	BORTEZOMIB NEAPOLIS	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	14,169,600 L.L
L01XG01	BORTEZOMIB GP PHARM	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	13,007,658 L.L
L01XG01	BORTEZOMIB ACCORD	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	13,007,658 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
L01XG01	BORCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder	11,020,381 L.L
J07AJ51	BOOSTRIX	B	Diphteria toxoid purified - ?2.5Lf/0.5ml, Tetanus toxoid purified - ?5Lf/0.5ml, Bordetella Pertussis Antigens: toxoid - 8mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 8mcg/0.5ml, Pertactine - 2.5mcg Al3+/0.5ml, Aluminium hydroxide - 0.3mg Al3+/0.5ml, Aluminium Phosphate - 0.2mg/0.5ml		Injectable suspension	1,394,909 L.L
M05BA06	BONVIVA	B	Ibandronic acid - 150mg	150mg	Tablet, film coated	1,265,900 L.L
M05BA06	BONVIVA	B	Ibandronic acid - 3mg/3ml	3mg/3ml	Injectable solution	3,144,591 L.L
H05AA02	BONTEO	BioTech	Teriparatide - 20mcg/dose	20mcg/dose		17,383,843 L.L
M05BA06	BONDRONAT	B	Ibandronic acid (monosodium monohydrate) - 6mg/6ml	6mg/6ml	Injectable concentrated powder for solution	24,963,868 L.L
M05BA06	BONAFOR	G	Ibandronic acid (monosodium monohydrate) - 150mg	150mg	Tablet, film coated	383,955 L.L
D01BA02	BODERM	G	Terbinafine HCl - 250mg	250mg	Tablet	749,992 L.L
C07AB12	BLOVEK	G	Nebivolol HCl - 5mg		Tablet	511,940 L.L
C09DA06	BLOPRESS PLUS 8MG	B	Candesartan cilexetil - 8mg, Hydrochlorothiazide - 12.5mg		Tablet	1,060,292 L.L
C09DA06	BLOPRESS PLUS 16MG	B	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg		Tablet	1,257,837 L.L
C09CA06	BLOPRESS	B	Candesartan cilexetil - 8mg	8mg	Tablet	847,965 L.L
C09CA06	BLOPRESS	B	Candesartan cilexetil - 16mg	16mg	Tablet	1,131,515 L.L
C07AB03	BLOKIUM 50MG	G	Atenolol - 50mg	50mg	Tablet	186,794 L.L
C07AB03	BLOKIUM 100MG	G	Atenolol - 100mg	100mg	Tablet	377,620 L.L
L01FX07	BLINCYTO	BioTech	Blinatumomab - 35mcg	35mcg	Injectable lyophilised powder for solution+stabilizer	239,484,334 L.L
L01DC01	BLEOCIN	B	Bleomycin (sulfate) - 15U	15U	Injectable lyophilised powder for solution	2,109,833 L.L
L01DC01	BLEO-CELL	G	Bleomycin (sulfate) - 15mg	15mg	Injectable powder for solution	3,054,554 L.L

نتائج تصنيف المستشفيات 2006